Racial and ethnic disparities in substance use disorders and outcomes in elderly prostate cancer patients
Racial and ethnic disparities in substance use disorders and outcomes in elderly prostate cancer patients
复制标题
DOI：
10.1080/15332640.2016.1160019
复制
发表时间：
2018-01-01
影响因子：
1.3
通讯作者：
Jayadevappa, Ravishankar
中科院分区：
文献类型：
--
作者：
Chhatre, Sumedha;Jayadevappa, Ravishankar
癌症患者的物质使用是一种重要的心理社会共病。目前，关于癌症患者在物质使用方面的种族差异的信息很少。这项研究的目的是利用监测、流行病学和最终结果(SEER)-医疗保险关联数据分析药物使用流行率的种族和民族差异及其对患有晚期前列腺癌的老年医疗保险结果的影响。我们使用ICD-9诊断代码来识别物质使用障碍。结果是卫生服务的使用、成本和死亡率。在患有晚期前列腺癌的白人、非裔美国人和西班牙裔患者中，药物使用的流行率各不相同。在药物使用与结果之间的关联中存在种族和民族差异。多学科协调护理方法对于解决前列腺癌患者在物质使用方面的种族和民族差异以及实现最佳临床管理和改善护理结果至关重要。
Substance use among cancer patients is an important psychosocial comorbidity. Currently, there is a paucity of information regarding racial disparity in substance use among cancer patients. The objective of this study was to analyze racial and ethnic disparity in prevalence of substance use and its effects on outcomes in Medicare elderly with advanced prostate cancer using Surveillance, Epidemiology, and End Results (SEER)-Medicare linked data. We used ICD-9 diagnosis codes to identify substance use disorder. Outcomes were health service use, cost, and mortality. Prevalence of substance use varied among White, African American, and Hispanic patients with advanced-stage prostate cancer. Racial and ethnic disparity existed in the association between substance use and outcomes. A multidisciplinary coordinated care approach is essential to address racial and ethnic disparities in substance use among prostate cancer patients and to achieve optimal clinical management and improved outcomes of care.